Abstract
The effect of an atypical β-adrenoceptor agonist, BRL-35135 on leukotriene B4-induced-guinea pig eosinophil chemotaxis was studied. BRL-35135 and SC-41930 (leukotriene B4-antagonist) inhibited the chemotaxis in a concentration-dependent manner (IC50=9.0×10−6 and 2.6×10−7 M, respectively). However, isoproterenol, fenoterol and another atypical β-agonist, BRL-37344 had no effects. The inhibitory effect of BRL-35135 was not affected by (±)-propranolol (10−4 M). In contrast, the nonselective β-adrenoceptor antagonist, (−)-alprenolol (10−4 M) dextrally shifted the inhibitory curve of BRL-35135. The response to BRL-35135 was antagonized in a competitive manner by (−)-alprenolol, with the slope of the Schild plot close to unity, and a pA 2 value of 5.62. These findings suggest that guinea pig eosinophils possess an “atypical receptor”, which differs from eitherβ 1,β 2 or atypical β-adrenoceptor on guinea pig ileum, and through which eosinophil chemotaxis can be modulated by BRL-35135.
Similar content being viewed by others
Abbreviations
- AR:
-
adrenoceptor
- CR:
-
concentration ratio
- EDTA:
-
ethylenediamine tetraacetic acid disodium salt
- DNase 1:
-
deoxyribonuclease 1
- HBSS:
-
Hanks' balanced salt solution
- LTB4 :
-
leukotriene B4
- IC50 :
-
50% inhibitory concentration
- mHBSS:
-
modified HBSS
- PBS:
-
Dulbecco's phosphate-buffered saline
References
T. Yukawa, D. Ukena, C. Kroegel, P. Chanez, G. Dent, K. F. Chung and P. J. Barnes,Beta 2-adrenergic receptors on eosinophils: Binding and functional studies. Am. Rev. Respir. Dis.141, 1446–1452 (1990).
H. H. Harms, J. Zaagsma and B. van der Wal,β-adrenoceptor studies III: On the β-adrenoceptors in rat adipose tissue. Eur. J. Pharmacol.25, 87–91 (1974).
H. H. Harms, J. Zaagsma and J. de Vente,Differentiation of β-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci.21, 123–128 (1977).
J. de Vente, A. Bast, L. van Bree and J. Zaagsma,β-adrenoceptor studies 6, further investigations on the hybrid nature of the rat adipocyte β-adrenoceptor. Eur. J. Pharmacol.63, 73–83 (1980).
C. Wilson, S. Wilson, V. Piercy, M. V. Sennitt and J. R. S. Arch,The rat lipolytic β-adrenoceptor: Studies using novel β-adrenoceptor agonists. Eur. J. Pharmacol.100, 309–319 (1984).
J. R. S. Arch, A. T. Ainsworth, M. A. Cawthorne, V. Piercy, M. V. Sennitt, V. E. Thody, C. Wilson and S. Wilson,Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature309, 163–165 (1984).
T. Croci, R. Cecchi, A. Tarantino, G. Aureggi, A. Bianchetti, R. Boigegrain and L. Manara,Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents. Pharmacol. Res. Commun.20, 147–151 (1988).
A. Bianchetti and L. Manara,In vitro inhibition of intestinal motility by phenylethanolaminotetralines: Evidence of atypical β-adrenoceptors in rat colon. Br. J. Pharmacol.100, 831–839 (1990).
D. P. McLaughlin and A. MacDonald,Evidence for the existence of ‘atypical’ β-adrenoceptors (β3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. Br. J. Pharmacol.101, 569–574 (1990).
R. A. Bond, K. G. Charlton and D. E. Clarke,Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists. J. Pharmacol. Exp. Ther.236, 408–415 (1986).
R. A. Bond, K. G. Charlton and D. E. Clarke,Evidence for a receptor mediated action of norepinephrine distinct from alpha- and beta-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol.334, 261–266 (1986).
R. A. Bond and D. E. Clarke,A response to isoprenaline unrelated to α- and β-adrenoceptor agonism. Br. J. Pharmacol.91, 683–686 (1987).
R. A. Bond and D. E. Clarke,Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α- and β-subtypes. Br. J. Pharmacol.95, 723–734 (1988).
D. R. Blue, R. A. Bond, N. Adham, R. Delmendo, A. D. Michel, R. M. Eglen, R. L. Whiting and D. E. Clarke,Antagonist characterization of atypical β adrenoceptors in guinea pig ileum: Blockade by alprenolol and dihydroalprenolol. J. Pharmacol. Exp. Ther.252, 1034–1042 (1990).
B. J. Norman and H. L. Leathard,Evidence that an atypical β-adrenoceptor mediates the inhibition of spontaneous rhythmical contractions of rabbit isolated jejunum induced by ritodrine and salbutamol. Br. J. Pharmacol.101, 27–30 (1990).
S. Thuda, M. Miyasato, K. Iryo, M. Ichiki, H. Kiyonaga, M. Kasada and Y. Sakai,Isolation of peritoneal eosinophils from polymyxin B-treated guinea pigs on density gradients of Nycodenz, a new non-ionic iodinated gradient medium. Biomedical Res.7, 389–397 (1986).
T. Fukuda, S. L. Dunnette, C. E. Reed, S. J. Ackerman, M. S. Peters and G. J. Gleich,Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am. Rev. Respir. Dis.132, 981–985 (1985).
F. Capsoni, F. Minonzio, A. M. Ongari and C. Zanussi,A new simplified single-filter assay for ‘in vitro’ evaluation of chemotaxis of 51 Cr-labeled polymorphonuclear leukocytes. J. Immunol. Methods.120, 125–131 (1989).
B. S. Tsai, D. Villani-Price, R. H. Keith, J. M. Zemaitis, R. F. Bauer, R. Leonard, S. W. Djuric and R. L. Shone,SC-41930: An inhibitor of leukotriene B 4-stimulated human neutrophil functions. Prostaglandins38, 655–674 (1989).
B. M. Czarnetzki and R. Mertensmeier,In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B 4 and its w-oxidation products. Prostaglandins30, 5–11 (1985).
B. M. Taylor, C. I. Czuk, M. N. Brunden, D. G. Wishka, J. Morris and F. F. Sun,Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B 4 antagonist U-75, 302. Adv. Prostaglandin Thromboxane Leukotriene Res.19, 195–198 (1989).
E. Coeffier, D. Joseph and B. B. Vargaftig,LTB 4,a potent chemotactic factor for purified guinea-pig eosinophils: Interference of PAF-acether antagonists. Int. J. Immunopharmacol.13, 273–280 (1991).
L. J. Emorine, S. Marullo, M.-M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko and A. D. Strosberg, Molecular characterization of the human β3-adrenergic. Science245, 1118–1121 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugasawa, T., Morooka, S. Effect of BRL-35135 on LTB4-induced guinea pig eosinophil chemotaxis. Agents and Actions 37, 232–237 (1992). https://doi.org/10.1007/BF02028114
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02028114